Thursday, November 23, 2017 | |
09:00
10:00
11:00
12:00
13:00
14:00
15:00
16:00
|
›9:05 (25min)
Welcome of participants
Julie GUILLERMET-GUIBERT (Cancer Research Center of Toulouse, Toulouse, France) › Pierre Fabre's Center for Research and Development, Auditorium
›9:30 (05min)
Introduction from the Directors
Gilles FAVRE (Cancer Research Center of Toulouse, Toulouse, France), Christian FILAQUIER (Pierre Fabre's Center for R&D, Toulouse, France) › Pierre Fabre's Center for Research and Development, Auditorium
›9:35 (45min)
› Pierre Fabre's Center for Research and Development, Auditorium
›10:20 (45min)
p110delta PI3K regulates gut immunity and inflammation by unconventional autophagy
Ezra AKSOY (William Harvey Institute, London, United Kingdom) › Pierre Fabre's Center for Research and Development, Auditorium
›11:05 (20min)
› Pierre Fabre's Center for Research and Development, Auditorium
›11:55 (20min)
› Pierre Fabre's Center for Research and Development, Auditorium
›12:15 (45min)
Synthetic Lethality screening identify ATR to synergize with oxaliplatin treatment in colorectal cancer
Celine GONGORA (Institute of Cancer Research of Montpellier, Montpellier, France) › Pierre Fabre's Center for Research and Development, Auditorium
›13:00 (15min)
›13:15 (1h15)
› Cancer Research Center of Toulouse, meeting-room Christophe Cazaux
›14:45 (20min)
› Pierre Fabre's Center for Research and Development, Auditorium
›15:05 (20min)
› Pierre Fabre's Center for Research and Development, Auditorium
›15:25 (45min)
Loss of PI3K-C2alpha in breast cancer leads to genomic instability but increases Taxane sensitivity
Emilio HIRSCH (University of Torino, Torino, Italy) › Pierre Fabre's Center for Research and Development, Auditorium
›16:10 (10min)
Conclusion & take-home messages
Julie GUILLERMET-GUIBERT (Cancer Research Center of Toulouse, Toulouse, France) › Pierre Fabre's Center for Research and Development, Auditorium
|
Session | Speech | Logistics | Break | Tour |